SENP1-IN-1

SENP1-IN-1

S647361-5mg

5mg

≥99%

-20°C储存

超低温冰袋运输

SENP1-IN-1 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 29. SENP1-IN-1 is developed for tumor radiosensitivity enhancement In Vitro SENP1-IN-1 may improve the sensitivity of tumor cells to irradiation. SENP1-IN-1 (0.7-20 μM; 72 hours)has cytotoxic for Hella cells with an IC 50 of >20μM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Cytotoxicity AssayCell Line: Hela cells Concentration: 0.7 μM, 2.2 μM, 6.6 μM, 20 μM Incubation Time: 72 hours Result: IC 50 >20 μM Form:Solid IC50& Target:SENP1

SENP1-IN-1 是一种特异性去 SUMOylation 蛋白酶 1（SENP1）抑制剂，提取自专利 CN110627860 第 29 号化合物。SENP1-IN-1 被开发用于提高肿瘤的放射敏感性。

2416910-69-3

C35H58N2O4

570.85 g/mol

CC1(C)[C@@H](O)CC[C@]2(C)[C@@]3([H])CC=C4[C@]5([H])[C@@H](C)[C@H](C)CC[C@@](C(NCC(N(CCO)C)=O)=O)5CC[C@](C)4[C@@](C)3CC[C@@]12[H]

DMSO : 100 mg/mL (175.18 mM; Need ultrasonic)